Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyAetna reduced copay drug coverage update | OpenPay…
    Ask Trek AI about this page
    CurrentAetnaPolicy N/A

    Reduced copay prescription drug coverage for Massachusetts chronic conditions

    Customize your policy alerts

    Sign up for all Aetna policy alerts

    Know when Aetna releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Describes reduced copay amounts for certain prescription drugs for Aetna members in Massachusetts with specified chronic conditions, effective starting July 1, 2025 and extending through 2026 with annual updates.

    Policy Summary
    PayerAetna
    PolicyReduced copay prescription drug coverage for Massachusetts chronic conditions
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateStarting July 1, 2025
    Next Review DateN/A
    Key ActionMembers with qualifying chronic conditions in Massachusetts may receive certain prescription drugs at reduced copays; contact Member Services for questions.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    $0copay level for listed generic drugs
    $25copay level for listed brand-name and insulin drugs
    Through 2026duration of lower-cost coverage
    3 chronic condition categoriesexamples listed

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Reduced Copay Coverage Criteria

    Reduced copay coverage criteria

    Covered when ALL of the following are met:

    Member is an Aetna member in Massachusetts.
    Member has a qualifying chronic condition (examples listed: asthma, diabetes, atrial fibrillation, coronary artery disease).

    ALL of the following

    • $0 copay — generic drugs

      • ALBUTEROL (generic) — $0 copay
      • SOTALOL (generic) — $0 copay
      • METOPROLOL/HYDROCHLOROTHIAZIDE (generic) — $0 copay
    • $25 copay — brand-name and insulin products

      • BREO ELLIPTA — $25 copay
      • ELIQUIS — $25 copay
      • BRILINTA — $25 copay
      • Insulin products (NOVOLIN 70/30 FLEXPEN; NOVOLIN N FLEXPEN; LANTUS SOLOSTAR; NOVOLOG; NOVOLIN R; TRESIBA FLEXTOUCH) — $25 copay
    The reduced copay amounts apply starting July 1, 2025 through 2026 and will be updated annually thereafter.
    Members should contact Member Services (number on back of ID card) for questions or further assistance.

    Drug Lists and Effective Period

    Generic drugs with $0 copayNDCCovered
    ALBUTEROL — $0 copay
    SOTALOL — $0 copay
    METOPROLOL/HYDROCHLOROTHIAZIDE — $0 copay
    Brand-name and insulin drugs with $25 copayNDCCovered
    BREO ELLIPTA — $25 copay
    ELIQUIS — $25 copay
    BRILINTA — $25 copay
    NOVOLIN 70/30 FLEXPEN — $25 copay
    NOVOLIN N FLEXPEN — $25 copay
    LANTUS SOLOSTAR — $25 copay
    NOVOLOG — $25 copay
    NOVOLIN R — $25 copay
    TRESIBA FLEXTOUCH — $25 copay
    Effective period
    Effective start dateLower costs apply starting July 1, 2025
    DurationCoverage of reduced copays continues through 2026
    Update cadenceReduced-cost list will be updated annually thereafter
    Member supportContact Member Services (number on back of ID card) for questions or assistance

    Member Assistance and Provider Guidance

    Documentation Required

    Member assistance and scope

    Starting July 1, 2025, Massachusetts law provides lower copays for certain prescription drugs for members with qualifying chronic conditions (examples: asthma, diabetes, and two specified heart problems). For questions or help confirming member eligibility or coverage, contact Member Services using the number on the back of the member’s ID card.

    Qualifying Chronic Conditions

    Qualifying chronic conditions
    AsthmaAsthma is listed as a qualifying chronic condition
    DiabetesDiabetes is listed as a qualifying chronic condition
    Cardiac — atrial fibrillationAtrial fibrillation is listed as a qualifying chronic condition
    Cardiac — coronary artery diseaseCoronary artery disease is listed as a qualifying chronic condition
    Policy Summary
    PayerAetna
    PolicyReduced copay prescription drug coverage for Massachusetts chronic conditions
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateStarting July 1, 2025
    Next Review DateN/A
    Key ActionMembers with qualifying chronic conditions in Massachusetts may receive certain prescription drugs at reduced copays; contact Member Services for questions.
    SourceLink
    On This Page
    Reduced Copay Coverage CriteriaDrug Lists and Effective PeriodMember Assistance and Provider GuidanceQualifying Chronic Conditions